Bionpharma
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2250 Perimeter Park Dr Ste 100, Morrisvi...Phone Number
(609) 380-3311Website
www.bionpharma.comRevenue
$17.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
1
1
1
About Bionpharma
Bionpharma specializes in researching, developing, and manufacturing high-quality generic medications and over-the-counter products. The company aims to influence the global pharmaceutical sector by providing affordable healthcare solutions, including a range of OTC products available on Amazon under the A+ Health brand. Bionpharma serves diverse needs with a commitment to quality, safety, and efficiency in its manufacturing and R&D processes. Their intended clients include consumers seeking accessible healthcare options and potential partners interested in pharmaceutical product development.Explore more
Bionpharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bionpharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Bionpharma is spiking on competitors!
Earning: See what the market has to say on Bionpharma recently announced quarterly report
Check if Bionpharma has recently received funding, and reach out quickly before it becomes old news!
Bionpharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Bionpharma
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Bionpharma had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Bionpharma has new funding data
Product Launch: Get notified when Bionpharma launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Bionpharma
Compare insights from companies similar to Bionpharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bionpharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bionpharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bionpharma.
Bionpharma Tech Stack
A closer look at the technologies used by Bionpharma
See more technologies
Bionpharma News & Media
Pharma Nobis, LLC Completes Acquisition of Fagron’s Contract Manufacturing Business and Manufacturing Facility, Names Todd Daviau CEO
NEW YORK--(BUSINESS WIRE)--An investment consortium led by Signet Healthcare Partners, Bionpharma, Inc and GMS Capital Partners LLC today announced it has formed Pharma Nobis, LLC (the “Company”) to acquire Fagron’s US contract manufacturing business. This business unit, operating from a manufacturing facility in Texarkana, Texas, provides contract manufacturing and private label services for consumer healthcare companies and retailers in the United States. Fagron will retain a 20% interest inCoreRx, Inc. announces approval & pending commercial launch of Amphetamine Sulfate Tablets with Bionpharma Inc.
CoreRx, Inc. announces approval & pending commercial launch of Amphetamine Sulfate Tablets with long-standing client Bionpharma Inc. CLEARWATER, FL, USA, March 27, 2020 /EINPresswire.com/ -- CoreRx, Inc. announces the approval and pending commercial …Abeona Therapeutics Announces Appointment of Stefano Buono and Richard Van Duyne to its Board of Directors
NEW YORK and CLEVELAND, May 14, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced that it is expanding its Board of Directors through the appointment of Messrs. Stefano Buono and Richard Van Duyne as independent Directors. Neither Mr. Buono nor Mr. Van Duyne has worked previously for the Company.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bionpharma
Sign Up For FreeTo access detailed company insights
Bionpharma specializes in researching, developing, and manufacturing high-quality generic medications and over-the-counter products. The company aims to influence the global pharmaceutical sector by providing affordable healthcare solutions, including a range of OTC products available on Amazon under the A+ Health brand. Bionpharma serves diverse n... Read More
